Decura Pharma SRL
Decura Pharma reported total assets of €12.0m at the end of the 2026 financial year (annual accounts filed with the NBB on 31 Oct 2026).
The score of Decura Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity +53 % Total assets +46 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Decura Pharma's annual accounts
Filed annual accounts
- Year ended 31 Mar 2026filed on 31 Oct 2026
- Year ended 31 Mar 2025filed on 30 Oct 2025
- Year ended 31 Mar 2024filed on 30 Oct 2024
- Year ended 31 Mar 2023filed on 30 Oct 2023
- Year ended 31 Mar 2022filed on 18 Oct 2022
Decura Pharma's financial analysis
- Solvency45.1%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Decura Pharma
Decura Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0817.127.010
- VAT number
- BE0817127010
- Peppol
- Registered · 0208:0817127010 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 15 Jul 2009
- Registered office
- 8400 Ostend
- Latest accounts
- 2026 · filed on 31 Oct 2026
- Activity
- Activities of holding companies (NACE 64210)
Decura Pharma (SRL) has been based in Ostend since 2009, active in: activities of holding companies. For 2026, it reports a net profit of €1.59m and equity of €5.42m; its revenue is not published. Its solvency stands at 45.1%, below the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Decura Pharma
Companies in the same business, of comparable size and area, outside its group.
- Magis Pharma Group Activities of holding companies Antwerp · balance sheet €13.0m
- VSF Management Business and other management consultancy activities Nandrin · balance sheet €11.3m
- Wisli Invest Activities of holding companies Beernem · balance sheet €28.4m
- Tube Holding Activities of head offices Antwerp · balance sheet €21.5m
- Etablissements A. Pasquasy Activities of holding companies Vilvoorde · balance sheet €45.4m
- Bluestone Retail sale of pharmaceutical products Ixelles · balance sheet €9.57m
- Medigroup Wholesale of pharmaceutical and medical goods Anderlecht · balance sheet €30.2m
- Wim de Marez Activities of holding companies Schaerbeek · balance sheet €8.97m
Frequently asked questions about Decura Pharma
What is the revenue of Decura Pharma?
Decura Pharma files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of Decura Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0817127010 for Decura Pharma, if the company is VAT-registered. Its company number (CBE) is 0817.127.010.
Where is the registered office of Decura Pharma?
According to the CBE register, the registered office of Decura Pharma is in 8400 Ostend.
What is the equity of Decura Pharma?
At the close of the 2026 financial year, the equity of Decura Pharma amounts to 5,423,399 €, a solvency of 45.1% of total assets.
Who manages Decura Pharma?
The register lists 2 active mandates at Decura Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Decura Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →